James Reddoch's Insider Trades & SAST Disclosures
James Reddoch's most recent trade in Royalty Pharma plc - Ordinary Shares - Class A was a trade of 100,000 Class A Ordinary Shares done at an average price of $41.2 . Disclosure was reported to the exchange on Sept. 28, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern James Reddoch.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Royalty Pharma plc - Ordin... | James Reddoch | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 41.23 per share. | 28 Sep 2022 | 100,000 | 820,800 | - | 41.2 | 4,122,670 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | James Reddoch | EVP & Chief Scientific Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Sep 2022 | 2,400 | 478,870 | - | - | LP interests in RPI US Partners 2019, LP | |
| Royalty Pharma plc - Ordin... | James Reddoch | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 41.56 per share. | 08 Jun 2022 | 100,000 | 920,800 | - | 41.6 | 4,155,900 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | James Reddoch | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 41.08 per share. | 27 May 2022 | 75,000 | 1,020,800 | - | 41.1 | 3,081,008 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | James Reddoch | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 40.44 per share. | 19 May 2022 | 75,000 | 1,095,800 | - | 40.4 | 3,033,128 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Sep 2021 | 5,128 | 481,270 | - | - | LP interests in RPI US Partners 2019, LP | |
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | Sale of securities on an exchange or to another person at price $ 39.78 per share. | 26 Jul 2021 | 8,949 | 1,170,800 | - | 39.8 | 355,977 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | Sale of securities on an exchange or to another person at price $ 39.78 per share. | 26 Jul 2021 | 8,949 | 1,170,800 | - | 39.8 | 355,977 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | Sale of securities on an exchange or to another person at price $ 42.01 per share. | 12 Jul 2021 | 17,832 | 1,179,751 | - | 42.0 | 749,081 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | Sale of securities on an exchange or to another person at price $ 42.04 per share. | 12 Jul 2021 | 100 | 1,197,583 | - | 42.0 | 4,204 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | Sale of securities on an exchange or to another person at price $ 42.00 per share. | 12 Jul 2021 | 2 | 1,179,749 | - | 42 | 84 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | Sale of securities on an exchange or to another person at price $ 42.05 per share. | 06 Jul 2021 | 40,655 | 1,197,683 | - | 42.0 | 1,709,380 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | Sale of securities on an exchange or to another person at price $ 42.40 per share. | 06 Jul 2021 | 30,270 | 1,240,530 | - | 42.4 | 1,283,560 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | Sale of securities on an exchange or to another person at price $ 42.01 per share. | 06 Jul 2021 | 2,192 | 1,238,338 | - | 42.0 | 92,087 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | Sale of securities on an exchange or to another person at price $ 44.60 per share. | 04 Jun 2021 | 100,000 | 1,370,800 | - | 44.6 | 4,459,730 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | Sale of securities on an exchange or to another person at price $ 46.43 per share. | 04 Jun 2021 | 50,000 | 1,270,800 | - | 46.4 | 2,321,540 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | Sale of securities on an exchange or to another person at price $ 46.57 per share. | 04 Jun 2021 | 47,790 | 1,323,010 | - | 46.6 | 2,225,523 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | Sale of securities on an exchange or to another person at price $ 47.01 per share. | 04 Jun 2021 | 2,210 | 1,320,800 | - | 47.0 | 103,896 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | Sale of securities on an exchange or to another person at price $ 42.13 per share. | 02 Jun 2021 | 50,000 | 1,470,800 | - | 42.1 | 2,106,560 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | 07 May 2021 | 1,320,800 | 1,520,800 | - | 0 | Class A Ordinary Shares | ||
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | 07 May 2021 | 132,080 | 486,398 | - | - | LP interests in RPI US Partners 2019, LP | ||
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | Sale of securities on an exchange or to another person at price $ 42.10 per share. | 14 Apr 2021 | 55,714 | 200,000 | - | 42.1 | 2,345,593 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | Sale of securities on an exchange or to another person at price $ 42.32 per share. | 12 Apr 2021 | 359 | 255,714 | - | 42.3 | 15,193 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | Sale of securities on an exchange or to another person at price $ 46.32 per share. | 22 Mar 2021 | 43,927 | 256,073 | - | 46.3 | 2,034,519 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | Sale of securities on an exchange or to another person at price $ 46.89 per share. | 02 Mar 2021 | 96,490 | 303,510 | - | 46.9 | 4,524,233 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | Sale of securities on an exchange or to another person at price $ 47.84 per share. | 02 Mar 2021 | 3,510 | 300,000 | - | 47.8 | 167,925 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | 31 Dec 2020 | 270,100 | 270,100 | - | 0 | Class A Ordinary Shares | ||
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | 31 Dec 2020 | 129,900 | 400,000 | - | 0 | Class A Ordinary Shares | ||
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | 31 Dec 2020 | 27,010 | 2,107 | - | - | LP interests in RPI US Partners 2019, LP | ||
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | 31 Dec 2020 | 12,990 | 618,478 | - | - | LP interests in RPI US Partners 2019, LP | ||
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2020 | 631,468 | 631,468 | - | - | LP interests in RPI US Partners 2019, LP | |
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2020 | 200,000 | 200,000 | - | - | ICAI Interests | |
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2020 | 29,117 | 29,117 | - | - | LP interests in RPI US Partners 2019, LP | |
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | 15 Jun 2020 | 25,030 | 25,030 | - | 0 | Class A Ordinary Shares | ||
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2020 | 2,698 | 2,698 | - | - | LP interests in RPI International Holdings 2019, LP | |
| Royalty Pharma plc - Ordin... | James Reddoch | EVP, Research & Investments | 15 Jun 2020 | 2,503 | 195 | - | - | LP interests in RPI International Holdings 2019, LP |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges